Teva Pharma Industries Ltd ADR (TEVA)

8.44
+0.04(+0.42%)
  • Volume:
    2,048,370
  • Day's Range:
    8.33 - 8.50
  • 52 wk Range:
    7.23 - 11.54

TEVA Overview

Prev. Close
8.4
Day's Range
8.33-8.5
Revenue
15.56B
Open
8.34
52 wk Range
7.23-11.54
EPS
-0.56
Volume
2,048,370
Market Cap
9.24B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
8,982,743
P/E Ratio
-
Beta
1.18
1-Year Change
-21.93%
Shares Outstanding
1,110,352,397
Next Earnings Date
Aug 04, 2022
What is your sentiment on Teva ADR?
or
Vote to see community's results!

Teva Pharma Industries Ltd ADR News

Teva Pharma Industries Ltd ADR Analysis

Teva Pharma Industries Ltd ADR Company Profile

Teva Pharma Industries Ltd ADR Company Profile

Employees
37736

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsNeutralStrong BuyStrong BuyBuyStrong Sell
SummaryBuyStrong BuyStrong BuyNeutralStrong Sell
  • 5
    0
    • soon below 7
      0
      • why this fall?
        0
        • bears loosin grip on teva's throat
          0
      • why this rise??
        0
        • Teva closes another compromise on painkillers, and will not have to admit claims about it
          0
        • tbh it's for me intriguing in US law to not to admit any liability and at the same time waive any future claims regarding especially this legal basis of liability
          0
      • I am out for now, sold Teva at 8.12$, takeing a loss. I will consider enter again at 7.4$. I think the down trend isn't over yet, because Teva problams not over, and rate hike will make her Det more expensive.
        2
        • Looks like i made a mistake… but pull back is likely to happen… maybe buy again at 7.60$
          1
        • it Will Come down again 🤷‍♂️
          0
      • IMO now 7.40$ is a good price to buy. This is good company with good profits every year.
        1
        • chart says 6 plus spike down - the general market might take it there. All bets of when deal arrives
          0
        • shy of 9 short though
          0
      • do like Warren amd dump this... get out and forget it
        1
        • think ur right i bought arrond 17🤷‍♂️🤷‍♂️
          0
        • Tom Christensen  close to bottom now,  maybe 6.5 i to bought around 17, think i buy some more one last time.
          0
      • optiods have positive use too.
        0
        • this is a good investment at this pri e, for sure.
          1
          • All the way to 11$.
            0